Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nika Skoro-Sajer

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Drugs|December 13, 2012
Optimal use of treprostinil in pulmonary arterial hypertension: a guide to the correct use of different formulationsNika Skoro-Sajer
Expert Review of Cardiovascular Therapy|November 4, 2014
Extended-release oral treprostinil for the treatment of pulmonary arterial hypertensionNika Skoro-Sajer, Irene Lang
Expert Opinion on Pharmacotherapy|May 14, 2008
Treprostinil for the treatment of pulmonary hypertensionNika Skoro-Sajer, Irene Lang
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 12, 2008
The role of treprostinil in the management of pulmonary hypertensionNika Skoro-Sajer, Irene Lang
Expert Opinion on Pharmacotherapy|January 8, 2014
Selexipag for the treatment of pulmonary arterial hypertensionNika Skoro-Sajer, Irene Marthe Lang
Vascular Health and Risk Management|October 2, 2008
Treprostinil for pulmonary hypertensionNika Skoro-Sajer, Irene Lang, Robert Naeije
Pulmonary Circulation|January 27, 2015
Right ventricle in acute and chronic pulmonary embolism (2013 Grover Conference series)Christian Gerges, Nika Skoro-Sajer, Irene M Lang
Zeitschrift Fur Rheumatologie|March 8, 2003
[Pulmonary hypertension in rheumatic diseases]Irene M Lang, Diana Bonderman, Nika Skoro-Sajer, et al.
Thrombosis and Haemostasis|June 24, 2004
Longitudinal analysis of perfusion lung scintigrams of patients with unoperated chronic thromboembolic pulmonary hypertensionNika Skoro-Sajer, Alexander Becherer, Walter Klepetko, et al.
Chest|October 21, 2005
Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertensionDiana Bonderman, Regina Nowotny, Nika Skoro-Sajer, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Drugs|December 13, 2012
Optimal use of treprostinil in pulmonary arterial hypertension: a guide to the correct use of different formulationsNika Skoro-Sajer
Expert Review of Cardiovascular Therapy|November 4, 2014
Extended-release oral treprostinil for the treatment of pulmonary arterial hypertensionNika Skoro-Sajer, Irene Lang
Expert Opinion on Pharmacotherapy|May 14, 2008
Treprostinil for the treatment of pulmonary hypertensionNika Skoro-Sajer, Irene Lang
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 12, 2008
The role of treprostinil in the management of pulmonary hypertensionNika Skoro-Sajer, Irene Lang
Expert Opinion on Pharmacotherapy|January 8, 2014
Selexipag for the treatment of pulmonary arterial hypertensionNika Skoro-Sajer, Irene Marthe Lang
Vascular Health and Risk Management|October 2, 2008
Treprostinil for pulmonary hypertensionNika Skoro-Sajer, Irene Lang, Robert Naeije
Pulmonary Circulation|January 27, 2015
Right ventricle in acute and chronic pulmonary embolism (2013 Grover Conference series)Christian Gerges, Nika Skoro-Sajer, Irene M Lang
Zeitschrift Fur Rheumatologie|March 8, 2003
[Pulmonary hypertension in rheumatic diseases]Irene M Lang, Diana Bonderman, Nika Skoro-Sajer, et al.
Thrombosis and Haemostasis|June 24, 2004
Longitudinal analysis of perfusion lung scintigrams of patients with unoperated chronic thromboembolic pulmonary hypertensionNika Skoro-Sajer, Alexander Becherer, Walter Klepetko, et al.
Chest|October 21, 2005
Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertensionDiana Bonderman, Regina Nowotny, Nika Skoro-Sajer, et al.
Pageof 4